{"entity":{"id":"nct05240898","kind":"trial","name":"A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of KSQ-4279 run by Hoffmann-La Roche, completed.","summary":"A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT05240898 by Hoffmann-La Roche, with 116 participants enrolled, started 2021-08-26, primary completion reached 2025-11-26. Conditions recorded: Advanced Solid Tumors. Interventions recorded: RO7623066, Olaparib, Carboplatin.","status":"completed","asOf":"2026-11-04","links":[{"label":"ClinicalTrials.gov NCT05240898","url":"https://clinicaltrials.gov/study/NCT05240898"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["ksq-4279"],"companies":["ksq-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05240898","phase":"1","setting":"A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors","sponsor":"Hoffmann-La Roche","enrolled":116,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05240898/","neighbours":{"drug":[{"id":"ksq-4279","kind":"drug","name":"KSQ-4279","route":"/drugs/ksq-4279/"}],"company":[{"id":"ksq-therapeutics","kind":"company","name":"KSQ Therapeutics","route":"/companies/ksq-therapeutics/"}]}}